OpenURL Connection Search

Select item for more details and to access through your institution.

A Randomized Study of Lenvatinib 18 mg vs 24 mg in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 3, p. 776, doi. 10.1210/clinem/dgab731
By:
- Brose, Marcia S.;
- Panaseykin, Yury;
- Konda, Bhavana;
- de la Fouchardiere, Christelle;
- Hughes, Brett G. M.;
- Gianoukakis, Andrew G.;
- Young Joo Park;
- Romanov, Ilia;
- Krzyzanowska, Monika K.;
- Leboulleux, Sophie;
- Binder, Terri A.;
- Dutcus, Corina;
- Ran Xie;
- Taylor, Matthew H.
Publication type:
Article
Quantified Immunohistochemistry Demonstrates Cellular Level Targets of an Oral Multikinase Inhibitor in Metastatic Thyroid Cancer.
Published in:
Laryngoscope, 2010, v. 120, n. S3, p. S47, doi. 10.1002/lary.21231
By:
- Ransom, Evan R.;
- Leibowitz, Jason M.;
- Ma, Cathy;
- Puttaswamy, Kanchan;
- Troxel, Andrea;
- Lee, William;
- Feldman, Michael;
- Brose, Marcia S.
Publication type:
Article
Understanding the Mechanism of Late Sorafenib Failure in Metastatic Thyroid Cancer.
Published in:
Laryngoscope, 2009, v. 119, n. S3, p. S237, doi. 10.1002/lary.21495
By:
- Cohen, Marc A;
- Ma, Changqing;
- Wang, Yan;
- Tang, Waixing;
- Olson, Jeffrey E;
- Brose, Marcia S
Publication type:
Article
Second-line treatment for advanced thyroid cancer: an indication in need of randomized clinical trials.
Published in:
2014
By:
- Cohen, Aaron B;
- Brose, Marcia S
Publication type:
Journal Article
Loss of Rap1GAP in papillary thyroid cancer.
Published in:
2009
By:
- Nellore, Anoma;
- Paziana, Karolina;
- Ma, Changqing;
- Tsygankova, Oxana M;
- Wang, Yan;
- Puttaswamy, Kanchan;
- Iqbal, Ammarah U;
- Franks, Susanna R;
- Lv, Yu;
- Troxel, Andrea B;
- Feldman, Michael D;
- Meinkoth, Judy L;
- Brose, Marcia S
Publication type:
journal article
Thyroid Cancer Update: Dramatic Changes in the Treatment of a Rare Disease.
Published in:
Oncology (08909091), 2009, v. 23, n. 9, p. 778
By:
- Brose, Marcia S.
Publication type:
Article
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.
Published in:
2002
By:
- Brose, Marcia S.;
- Rebbeck, Timothy R.;
- Calzone, Kathleen A.;
- Stopfer, Jill E.;
- Nathanson, Katherine L.;
- Weber, Barbara L.
Publication type:
journal article
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study
Published in:
Thyroid, 2024, v. 34, n. 3, p. 347, doi. 10.1089/thy.2023.0463
By:
- Capdevila, Jaume;
- Krajewska, Jolanta;
- Hernando, Jorge;
- Robinson, Bruce;
- Sherman, Steven I.;
- Jarzab, Barbara;
- Lin, Chia-Chi;
- Vaisman, Fernanda;
- Hoff, Ana O.;
- Hitre, Erika;
- Bowles, Daniel W.;
- Williamson, Denise;
- Levytskyy, Roman;
- Oliver, Jennifer;
- Keam, Bhumsuk;
- Brose, Marcia S.
Publication type:
Article
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI).
Published in:
Thyroid, 2022, v. 32, n. 9, p. 1059, doi. 10.1089/thy.2022.0061
By:
- Brose, Marcia S.;
- Smit, Johannes W.A.;
- Lin, Chia-Chi;
- Tori, Masayuki;
- Bowles, Daniel W.;
- Worden, Francis;
- Shen, Daniel Hueng-Yuan;
- Huang, Shih-Ming;
- Tsai, Hui-Jen;
- Alevizaki, Maria;
- Peeters, Robin P.;
- Takahashi, Shunji;
- Rumyantsev, Pavel;
- Guan, Rongjin;
- Babajanyan, Svetlana;
- Ozgurdal, Kirhan;
- Sugitani, Iwao;
- Pitoia, Fabian;
- Lamartina, Livia
Publication type:
Article
Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial.
Published in:
Thyroid, 2019, v. 29, n. 12, p. 1820, doi. 10.1089/thy.2018.0784
By:
- Huillard, Olivier;
- Jouinot, Anne;
- Tlemsani, Camille;
- Brose, Marcia S.;
- Arrondeau, Jennifer;
- Meinhardt, Gerold;
- Fellous, Marc;
- De Sanctis, Yoriko;
- Schlumberger, Martin;
- Goldwasser, Francois
Publication type:
Article
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
Published in:
European Journal of Endocrinology, 2022, v. 186, n. 6, p. 631, doi. 10.1530/eje-21-1259
By:
- Waguespack, Steven G.;
- Drilon, Alexander;
- Lin, Jessica J.;
- Brose, Marcia S;
- McDermott, Ray;
- Almubarak, Mohammed;
- Bauman, Jessica;
- Casanova, Michela;
- Krishnamurthy, Anuradha;
- Kummar, Shivaani;
- Leyvraz, Serge;
- Do-Youn Oh;
- Park, Keunchil;
- Sohal, Davendra;
- Sherman, Eric;
- Norenberg, Ricarda;
- Silvertown, Josh D.;
- Brega, Nicoletta;
- Hong, David S.;
- Cabanillas, Maria E.
Publication type:
Article
Health‐related quality‐of‐life analyses from a multicenter, randomized, double‐blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day.
Published in:
Cancer Medicine, 2023, v. 12, n. 4, p. 4332, doi. 10.1002/cam4.5308
By:
- Taylor, Matthew H.;
- Leboulleux, Sophie;
- Panaseykin, Yury;
- Konda, Bhavana;
- de La Fouchardiere, Christelle;
- Hughes, Brett G. M.;
- Gianoukakis, Andrew G.;
- Park, Young Joo;
- Romanov, Ilia;
- Krzyzanowska, Monika K.;
- Garbinsky, Diana;
- Sherif, Bintu;
- Pan, Jie Janice;
- Binder, Terri A.;
- Sauter, Nicholas;
- Xie, Ran;
- Brose, Marcia S.
Publication type:
Article
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas.
Published in:
Neuro-Oncology, 2010, v. 12, n. 7, p. 621, doi. 10.1093/neuonc/noq007
By:
- Dougherty, Margaret J.;
- Santi, Mariarita;
- Brose, Marcia S.;
- Ma, Changqing;
- Resnick, Adam C.;
- Sievert, Angela J.;
- Storm, Phillip B.;
- Biegel, Jaclyn A.
Publication type:
Article
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer.
Published in:
American Journal of Managed Care, 2022, v. 28, p. S26, doi. 10.37765/ajmc.2022.88845
By:
- Carlson, Josh J.;
- Italiano, Antoine;
- Brose, Marcia S.;
- Federman, Noah;
- Lassen, Ulrik;
- Kummar, Shivaani;
- Sullivan, Sean D.
Publication type:
Article
Diagnosis and Management of TRK Fusion Cancer.
Published in:
American Journal of Managed Care, 2022, v. 28, p. S15, doi. 10.37765/ajmc.2022.88834
By:
- Kummar, Shivaani;
- Italiano, Antoine;
- Brose, Marcia S.;
- Carlson, Josh J.;
- Sullivan, Sean D.;
- Lassen, Ulrik;
- Federman, Noah
Publication type:
Article
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer.
Published in:
American Journal of Managed Care, 2022, v. 28, p. S26, doi. 10.37765/ajmc.2022.88845
By:
- Carlson, Josh J.;
- Italiano, Antoine;
- Brose, Marcia S.;
- Federman, Noah;
- Lassen, Ulrik;
- Kummar, Shivaani;
- Sullivan, Sean D.
Publication type:
Article
Diagnosis and Management of TRK Fusion Cancer.
Published in:
American Journal of Managed Care, 2022, v. 28, p. S15, doi. 10.37765/ajmc.2022.88834
By:
- Kummar, Shivaani;
- Italiano, Antoine;
- Brose, Marcia S.;
- Carlson, Josh J.;
- Sullivan, Sean D.;
- Lassen, Ulrik;
- Federman, Noah
Publication type:
Article
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.
Published in:
2019
By:
- Mehnert, Janice M.;
- Varga, Andrea;
- Brose, Marcia S.;
- Aggarwal, Rahul R.;
- Lin, Chia-Chi;
- Prawira, Amy;
- de Braud, Filippo;
- Tamura, Kenji;
- Doi, Toshihiko;
- Piha-Paul, Sarina A.;
- Gilbert, Jill;
- Saraf, Sanatan;
- Thanigaimani, Pradeep;
- Cheng, Jonathan D.;
- Keam, Bhumsuk
Publication type:
journal article
Targeted Oncogene Therapy Before Surgery in Pediatric Patients With Advanced Invasive Thyroid Cancer at Initial Presentation: Is It Time for a Paradigm Shift?
Published in:
2020
By:
- Kazahaya, Ken;
- Prickett, Kara K.;
- Paulson, Vera A.;
- Dahl, John P.;
- Manning, Scott C.;
- Rudzinski, Erin R.;
- Rastatter, Jeffrey C.;
- Parikh, Sanjay R.;
- Hawkins, Douglas S.;
- Brose, Marcia S.;
- Bauer, Andrew J.
Publication type:
journal article
Population Pharmacokinetics and Exposure–Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer.
Published in:
Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 587, doi. 10.1007/s40262-023-01210-0
By:
- Ly, Neang S.;
- Li, Jing;
- Faggioni, Raffaella;
- Roskos, Lorin K.;
- Brose, Marcia S.
Publication type:
Article
A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer.
Published in:
Thyroid, 2014, v. 24, n. 10, p. 1508, doi. 10.1089/thy.2014.0125
By:
- Cabanillas, Maria E.;
- Brose, Marcia S.;
- Holland, Jaymes;
- Ferguson, Kimberly C.;
- Sherman, Steven I.
Publication type:
Article
Exposure–Response Modeling and Simulation of Progression‐Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer.
Published in:
CTS: Clinical & Translational Science, 2019, v. 12, n. 5, p. 459, doi. 10.1111/cts.12634
By:
- Grevel, Joachim;
- Jentsch, Garrit;
- Austin, Rupert;
- Prins, Nicolaas H.;
- Lettieri, John;
- Mitchell, David;
- Huang, Funan;
- Brose, Marcia S.;
- Schlumberger, Martin;
- Meinhardt, Gerold;
- Peña, Carol E. A.;
- Ploeger, Bart A.
Publication type:
Article
Best Use of the Tyrosine Kinase Inhibitors in Progressive Differentiated Thyroid Cancer: Discussion.
Published in:
Clinical Advances in Hematology & Oncology, 2016, v. 14, p. 12
By:
- Tuttle, R. Michael;
- Brose, Marcia S.
Publication type:
Article
Sequencing of Tyrosine Kinase Inhibitors in Progressive Differentiated Thyroid Cancer.
Published in:
Clinical Advances in Hematology & Oncology, 2016, v. 14, p. 7
By:
- Brose, Marcia S.
Publication type:
Article
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
Published in:
Head & Neck, 2022, v. 44, n. 6, p. 1277, doi. 10.1002/hed.27025
By:
- Shonka, David C.;
- Ho, Alan;
- Chintakuntlawar, Ashish V.;
- Geiger, Jessica L.;
- Park, Jong C.;
- Seetharamu, Nagashree;
- Jasim, Sina;
- Abdelhamid Ahmed, Amr H.;
- Bible, Keith C.;
- Brose, Marcia S.;
- Cabanillas, Maria E.;
- Dabekaussen, Kirsten;
- Davies, Louise;
- Dias‐Santagata, Dora;
- Fagin, James A.;
- Faquin, William C.;
- Ghossein, Ronald A.;
- Gopal, Raj K.;
- Miyauchi, Akira;
- Nikiforov, Yuri E.
Publication type:
Article
Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
Published in:
2018
By:
- Wirth, Lori J.;
- Tahara, Makoto;
- Robinson, Bruce;
- Francis, Sanjeev;
- Brose, Marcia S.;
- Habra, Mouhammed Amir;
- Newbold, Kate;
- Kiyota, Naomi;
- Dutcus, Corina E.;
- Mathias, Elton;
- Guo, Matthew;
- Sherman, Steven I.;
- Schlumberger, Martin
Publication type:
journal article
Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
Published in:
2016
By:
- Sherman, Steven I.;
- Clary, Douglas O.;
- Elisei, Rossella;
- Schlumberger, Martin J.;
- Cohen, Ezra E. W.;
- Schöffski, Patrick;
- Wirth, Lori J.;
- Mangeshkar, Milan;
- Aftab, Dana T.;
- Brose, Marcia S.
Publication type:
journal article
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
Published in:
2022
By:
- Yang, James C. H.;
- Brose, Marcia S.;
- Castro, Gilberto;
- Kim, Edward S.;
- Lassen, Ulrik N.;
- Leyvraz, Serge;
- Pappo, Alberto;
- López-Ríos, Fernando;
- Reeves, John A.;
- Fellous, Marc;
- Penault-Llorca, Frédérique;
- Rudzinski, Erin R.;
- Tabatabai, Ghazaleh;
- Vassal, Gilles;
- Drilon, Alexander;
- Trent, Jonathan
Publication type:
journal article
Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.
Published in:
Oncologist, 2024, v. 29, n. 6, p. e779, doi. 10.1093/oncolo/oyac080
By:
- Le, Xiuning;
- Baik, Christina;
- Bauman, Jessica;
- Gilbert, Jill;
- Brose, Marcia S;
- Grilley-Olson, Juneko E;
- Patil, Tejas;
- McDermott, Ray;
- Raez, Luis E;
- Johnson, Jennifer M;
- Shen, Lin;
- Tahara, Makoto;
- Ho, Alan L;
- Norenberg, Ricarda;
- Dima, Laura;
- Brega, Nicoletta;
- Drilon, Alexander;
- Hong, David S
Publication type:
Article
Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial.
Published in:
Cancer (0008543X), 2022, v. 128, n. 24, p. 4203, doi. 10.1002/cncr.34493
By:
- Brose, Marcia S.;
- Robinson, Bruce G.;
- Sherman, Steven I.;
- Jarzab, Barbara;
- Lin, Chia‐Chi;
- Vaisman, Fernanda;
- Hoff, Ana O.;
- Hitre, Erika;
- Bowles, Daniel W.;
- Sen, Suvajit;
- Oliver, Jennifer W.;
- Banerjee, Kamalika;
- Keam, Bhumsuk;
- Capdevila, Jaume
Publication type:
Article
R009: Copy Number Alterations and Aberrant Transcription of CSMD1
Published in:
2006
By:
- Sparano, Anthony;
- Quesnelle, Kelly M.;
- Park, Min S.;
- Brose, Marcia S.
Publication type:
Abstract
R009: Copy Number Alterations and Aberrant Transcription of CSMD1.
Published in:
2006
By:
- Sparano, Anthony;
- Quesnelle, Kelly M;
- Park, Min S;
- Brose, Marcia S
Publication type:
Abstract
Gene Copy Number Alterations Involving CSMD1 in Oral Squamous Cell Carcinoma
Published in:
2005
By:
- Sparano, Anthony;
- Kumar, Madhu S.;
- Quesnelle, Kelly M.;
- Brose, Marcia S.
Publication type:
Abstract

Found: 33